CSL Seqirus to supply UK with AUJEMFLU flu shot from 2027/28 season
CSL unit Seqirus has secured a UK rollout of its adjuvanted cell-based flu vaccine AUJEMFLU starting in the 2027/28 season. UKHSA has extended its pandemic Advance Purchase Agreement with Seqirus through 2031, supporting influenza outbreak readiness. The deal includes an option for the UK to buy more than 100 million d